about
Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.Reactions of hydrophobic organic nanoparticle mixtures in water: nanoparticle-on-nanoparticle oxidative dye bleaching
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Nanomedicines for HIV therapy.
@en
Nanomedicines for HIV therapy.
@nl
type
label
Nanomedicines for HIV therapy.
@en
Nanomedicines for HIV therapy.
@nl
prefLabel
Nanomedicines for HIV therapy.
@en
Nanomedicines for HIV therapy.
@nl
P2860
P50
P356
P1433
P1476
Nanomedicines for HIV therapy.
@en
P2093
Philip Martin
P2860
P304
P356
10.4155/TDE.12.156
P577
2013-02-01T00:00:00Z